![Andrew technologies](/api/images/company-pic/0-1780903-company.png)
Свяжитесь с нами
О компании
Andrew Technologies, LLC, is a medical technology company with a proprietary surgical innovation called Tissue Liquefaction Technology:tm:. The first product to utilize TLT was launched in 2003 by Alcon for cataract surgery. In 2012, the FDA cleared HydraSolve:registered: Lipoplasty System. Andrew Technologies also has an impressive research pipeline focused on stem cells and diabetes.
US
Неизвестно
Не проверенная компания
Прозрачность бизнеса
- Не проверена информация о компании
- Спрашивает отзывы у своих клиентов
- Не ответил на негативные отзывы